17 key players in the global spine biologics market

Written by Shayna Korol | August 20, 2018 | Print  | Email

The global spine biologics market is expected to grow at a 4.4 percent compound annual growth rate to reach more than $2.6 billion by 2022, according to a Market Research Engine report.

Here are 17 key market players:

1. DePuy Spine

2. Precision Spine

3. Medtronic

4. Stryker

5. Smith & Nephew

6. Orthovita

7. Zimmer Spine

8. K2M

9. NuVasive

10. Arthrex

11. DMP Spine

12. Alphatec Spine

13. Orthofix

14. RTI Surgical

15. Wright Medical Technology

16. Cesca Therapeutics

17. Lattice Biologics

More articles on biologics:
Paragon 28 launches bone graft harvesting system for foot and ankle: 4 insights
BioRestorative Therapies publishes study examining stem cell treatment for DDD
U of Minnesota 3D-prints stem cells for spinal cord repair: 5 things to know

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.